Jagsonpal Pharmaceuticals Ltd.
| BSE: 507789 | Sector: Health care |
| NSE: JAGSNPHARM | ISIN Code: INE048B01027 |
| BSE 00:00 | 24 Sep | 152.05 |
-2.05 (-1.33%) |
OPEN
153.90 |
HIGH
155.95 |
LOW
150.65 |
| NSE 00:00 | 24 Sep | 151.45 |
-2.55 (-1.66%) |
OPEN
155.95 |
HIGH
155.95 |
LOW
150.00 |
| OPEN | 153.90 |
| PREVIOUS CLOSE | 154.10 |
| VOLUME | 9229 |
| 52-Week high | 203.25 |
| 52-Week low | 35.45 |
| P/E | 18.63 |
| Mkt Cap.(Rs cr) | 398 |
| Buy Price | 0.00 |
| Buy Qty | 0.00 |
| Sell Price | 0.00 |
| Sell Qty | 0.00 |
Jagsonpal Pharmaceuticals Ltd. (JAGSNPHARM) - Market Capital
Market Cap
| COMPANY | LATEST(Rs) | CHG(%) | 52 Wk High | 52 Wk Low | MKT-CAP (RS CR) |
| Sun Pharma.Inds. | 769.70 | -0.01 | 804.40 | 452.60 | 184674.12 |
| Divi's Lab. | 5101.80 | -2.13 | 5269.00 | 2986.70 | 135427.28 |
| Dr Reddy's Labs | 4792.80 | -0.07 | 5613.65 | 4135.90 | 79752.19 |
| Cipla | 967.00 | -0.11 | 997.20 | 706.45 | 78003.06 |
| Apollo Hospitals | 4732.45 | -7.10 | 5183.30 | 1762.40 | 68043.17 |
| Piramal Enterp. | 2772.35 | -0.24 | 2856.80 | 1178.85 | 66162.13 |
| Gland Pharma | 3847.40 | -1.60 | 4350.00 | 1701.00 | 63174.31 |
| Cadila Health. | 564.75 | -0.38 | 673.70 | 373.95 | 57813.46 |
| Torrent Pharma. | 3100.25 | -0.06 | 3226.05 | 2311.30 | 52462.43 |
| Alkem Lab | 4001.85 | 0.95 | 4067.70 | 2544.25 | 47842.12 |
| Abbott India | 21189.15 | -1.85 | 21850.00 | 13970.10 | 45026.94 |
| Biocon | 360.20 | -2.07 | 487.70 | 327.75 | 43245.61 |
| Aurobindo Pharma | 722.10 | -1.57 | 1063.75 | 660.10 | 42307.84 |
| Lupin | 926.20 | -1.51 | 1267.50 | 856.00 | 42054.11 |
| Max Healthcare | 365.15 | -1.66 | 472.60 | 102.50 | 35271.66 |
| Laurus Labs | 609.80 | -1.95 | 723.55 | 249.29 | 32721.87 |
| Dr Lal Pathlabs | 3890.50 | -3.70 | 4243.00 | 1762.40 | 32423.43 |
| Ipca Labs. | 2402.10 | -2.97 | 2767.10 | 1786.05 | 30470.64 |
| Pfizer | 5704.90 | -2.00 | 6164.80 | 4200.00 | 26099.92 |
| Syngene Intl. | 644.90 | -1.93 | 699.95 | 490.35 | 25847.59 |
Quick Links for Jagsonpal Pharmaceuticals:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices
